Table 1.
Overview of the studies included in the meta-analysis.
References | Methods for determining the infarct size | Sample size (n) | Melatonin administration | Reperfusion medical strategies | Target disease | Effect | Risk of bias |
---|---|---|---|---|---|---|---|
Gögenur et al. (15) | Levels of troponin I | 50 | Melatonin orally and intraoperatively | CABG | Elective abdominal aortic aneurysm repair | CP | High |
Ghaeli et al. (16) | Levels of troponin T | 40 | Melatonin orally | PCI | AMI | No effect | High |
Dwaich et al. (17) | LVEF, levels of troponin I | 45 | Melatonin orally | CABG | CABG | CP | Low |
Ekeloef et al. (18) | Levels of troponin T, LVEF, and CRM | 48 | IV and IC melatonin | PCI | AMI | No effect | Low |
Dominguez-Rodriguez et al. (19) | Levels of troponin I, LVEF, and CRM | 125 | IV and IC melatonin | PCI | AMI | CP in the first tertile (early after symptom onset) | Low |
Shafiei et al. (20) | LVEF | 88 | Melatonin orally | CABG | CABG | CP | Low |
AMI, acute myocardial infarction; CABG, coronary artery bypass grafting; CP, cardioprotection; CRM, cardiovascular magnetic resonance; IC, intracoronary; IV, intravenous; LVEF, left ventricular ejection fraction; PCI; percutaneous coronary intervention.